Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06297343
Recruiting Observational

Study of the Risk of Ischaemia Following the Creation of an Arteriovenous Fistula

NCT06297343 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-10-20
Last updated
2025-11-24

Condition(s) studied

Renal Failure

Investigational drug(s) / intervention(s)

Creation of an arteriovenous fistula

Creation of an arteriovenous fistula: Patients will undergo the surgical procedure to create an arteriovenous fistula and will be discharged the same day (outpatient care, or an overnight stay in hospital if they live a long way from the hospital, have multiple pathologies or are socially isolated). An arteriovenous fistula is created under local or general anaesthetic. On the day of the operation, the type of arteriovenous fistula created, the side of the arteriovenous fistula, the location of the arteriovenous fistula and the patency of the arteriovenous fistula will be collected.

Study summary

The purpose of this study is to identify functional vascular changes and clinical factors correlated with the occurrence of short- or medium-term hand ischaemia after arteriovenous fistula creation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years; * Stage 5 chronic kidney disease, on dialysis or not on dialysis; * Requiring the creation of an arteriovenous fistula; * Membership of a social insurance scheme; * Patient having been informed and having formulated his/her oral non-opposition to participate in the research. Exclusion Criteria: * Contraindication to the proposed surgery ; * Reduced life expectancy in the opinion of the investigator; * Medical or biological conditions which, in the opinion of the investigator, could influence the interpretation of the results of the study or the safety of the patient; * Patient uncooperative with protocol requirements or unable to attend scheduled visits to the centre; * Other surgical or medical intervention planned during the study; * Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding; * Participating in another clinical trial, or in a period of exclusion from another clinical trial; * Patient under guardianship or deprived of liberty.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital Privé des Peupliers Paris France Recruiting

More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06297343 on ClinicalTrials.gov ↗ ← All trials in France